Using Survey Data and Qualitative Interviews to Support Content Validity for Spinocerebellar Ataxia (SCA) Patients


Suminski N1, Gold A1, Doma R1, Rudell K2, L'Italien G3, Potashman M3
1Parexel International LLC, Durham, NC, USA, 2Parexel International LLC, LONDON, LON, UK, 3Biohaven Pharmaceuticals, New Haven, CT, USA

OBJECTIVES: Qualitative research enables an in-depth understanding of the patient experience, however, attaining a sufficient sample size to determine the content validity of a Clinical Outcomes Assessment (COA) instrument can be challenging, especially in rare diseases. The FDA Patient Focused Drug Development guidance mentions surveys as an appropriate method to inform content validity. We utilized survey data along with concept elicitation (CE) interview data to achieve concept confirmation to support content validity for three COAs in the SCA population.

METHODS: A cross-sectional survey was completed by 147 patients with Cerebellar Ataxia (CA). Respondents were asked to describe all the symptoms and impacts associated with their disease. CE interviews were conducted with SCA patients. Concept confirmation was evaluated by mapping concepts collected from both data sources against the three COAs of interest (f-SARA, PIFAS, FARS-ADL).

RESULTS: All concepts in the COAs were endorsed by the surveys and/or interviews. 65 signs/symptoms (16 domains) and 56 impacts (7 domains) were reported across sources. The domains were consistent between interviews and survey (e.g., walking, stance/balance, etc.), noting a depth of information was captured for individual concepts in the survey as compared to the interviews alone (i.e., 29 signs/symptoms and 15 impacts were elicited from the survey only). For example, while the domain “stance/balance” was endorsed by both sources, interviewees and survey participants reported “balance (e.g., trouble keeping balance)” while only survey participants reported “coordination”, highlighting a specific dimension of the domain not captured by the interviews alone. The combination of survey and interview data sources strengthened the concept relevance, highlighting what is important to patients.

CONCLUSIONS: Survey data was combined with qualitative interviews as a mixed method approach to support the content validation of three SCA COA instruments used in a clinical trial. This approach may be preferable to elicit a more comprehensive perspective of the patient experience.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)




Clinical Outcomes, Patient-Centered Research

Topic Subcategory

Clinical Outcomes Assessment, Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes


Neurological Disorders, No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now